Graf Akcie NKTR (Nektar Therapeutics). Diskuze k akciím NKTR. Aktuální informace NKTR.

Základní informace o společnosti Nektar Therapeutics (Akcie NKTR)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 3.11B
Hodnota podniku (EV) 2.26B
Tržby 105.472M
EBITDA -419.79
Zisk -474.28
Růst v tržbách Q/Q -42.00 %
Růst v tržbách Y/Y -35.09 %
P/E (Cena vůči ziskům) N/A
Forward P/E -20.85
EV/Sales 21.40
EV/EBITDA N/A
EV/EBIT N/A
PEG 0.91
Price/Sales 29.51
P/FCF N/A
Price/Book 2.89
Účetní hodnota na akcii 5.99
Hotovost na akcii 5.91
FCF vůči ceně -10.32 %
Počet zaměstnanců 718
Tržba na zaměstnance 146.897k
Profit margin -290.65 %
Operating margin -410.88 %
Gross margin 87.26 %
EBIT margin -449.10 %
EBITDA margin -398.01 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 53.33 %
EPS - Očekávaný růst příští rok 31.15 %
Return on assets -32.29 %
Return on equity -45.74 %
ROIC -24.86 %
ROCE -38.19 %
Dluhy/Equity 0.43
Čistý dluh/EBITDA 8.22
Current ratio 8.06
Quick Ratio 7.95
Volatilita 4.02
Beta 0.90
RSI 52.65
Cílová cena analytiků 31
Známka akcie (dle analytiků) 1.80
Insider ownership 0.96 %
Institutional ownership 94.36 %
Počet akcií 183.801M
Procento shortovaných akcií 20.09 %
Short ratio 19.92 %
Dividenda 0.00
Procentuální dividenda 0.00 %
Dividenda/Zisk N/A %
Obchodovaná od 1994
Země United States

Finanční výsledky akcie NKTR

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$114.617$1,193.323$307.711$165.436$230.784$200.707
Cost Of Goods Sold$21.374$24.412$30.547$30.215$34.102$28.533
Gross Profit$93.243$1,168.911$277.164$135.221$196.682$172.174
Research And Development Expenses$434.566$399.536$268.461$203.801$182.787$147.734
SG&A Expenses$98.712$81.443$52.364$44.275$43.266$40.925
Other Operating Income Or Expenses--$-15.981---
Operating Expenses$554.652$505.391$367.353$278.291$260.155$217.192
Operating Income$-440.035$687.932$-59.642$-112.855$-29.371$-16.485
Total Non-Operating Income/Expense$-0.019$-5.207$-36.434$-39.793$-51.3$-37.943
Pre-Tax Income$-440.054$682.725$-96.076$-152.648$-80.671$-54.428
Income Taxes$0.613$1.412$0.616$0.876$0.506$-0.512
Income After Taxes$-440.667$681.313$-96.692$-153.524$-81.177$-53.916
Other Income------
Income From Continuous Operations$-440.667$681.313$-96.692$-153.524$-81.177$-53.916
Income From Discontinued Operations------
Net Income$-440.667$681.313$-96.692$-153.524$-81.177$-53.916
EBITDA$-426.879$698.802$-44.901$-97.504$-16.516$-3.558
EBIT$-440.035$687.932$-59.642$-112.855$-29.371$-16.485
Basic Shares Outstanding175170156140132127
Shares Outstanding175180156140132127
Basic EPS$-2.52$4.02$-0.62$-1.10$-0.61$-0.42
EPS - Earnings Per Share$-2.52$3.78$-0.62$-1.10$-0.61$-0.42
# 2020 2019 2018 2017 2016 2015
Current Ratio4.016917.53235.81915.89785.71554.4998
Long-term Debt / Capital-0.12570.73630.73420.97420.7804
Debt/Equity Ratio0.1770.14382.79192.762738.50183.6786
Gross Margin81.351897.954390.072881.736285.223485.7838
Operating Margin-383.917757.6484-19.3825-68.2167-12.7266-8.2135
EBIT Margin-383.917757.6484-19.3825-68.2167-12.7266-8.2135
EBITDA Margin-372.439558.5593-14.5919-58.9376-7.1565-1.7727
Pre-Tax Profit Margin-383.934357.2121-31.2228-92.2701-34.9552-27.1181
Net Profit Margin-384.469157.0938-31.423-92.7996-35.1745-26.863
Asset Turnover0.0580.5550.60470.29080.46280.4545
Inventory Turnover Ratio1.68762.1452.84792.71993.00562.203
Receiveable Turnover3.114427.614961.370410.552111.569955.6438
Days Sales In Receivables117.196713.21755.947534.590231.54756.5596
ROE - Return On Equity-31.355539.6671-110.0925-174.212-1262.669-148.3984
Return On Tangible Equity-33.160541.5163-853.6414-1320.754115.848134.2229
ROA - Return On Assets-22.285731.6864-19.0015-26.9875-16.2796-12.2087
ROI - Return On Investment-31.355534.6808-29.0336-46.2995-32.5749-32.5834
Book Value Per Share7.96239.89790.55060.57520.04750.2769
Operating Cash Flow Per Share-5.86574.5030.3227-0.28660.5676-0.7864
Free Cash Flow Per Share-5.95154.50070.3064-0.24780.5616-0.8297